Interestingly, a recent study pointed to the therapeutic potential of oral Ang-(1–7) peptide in obese mice by modulating the intestinal microbiota (reduction in Firmicutes/Bacteroidetes ratio), suggesting the involvement of RAS in obesity, gut dysbiosis, COVID-19, and ALI/ARDS [62]. The gene discussed is ANG; the disease is acute respiratory distress syndrome.